23andMe gets FDA go-ahead to provide pharmacogenetic reports on statin 01-Nov-2022 By Ben Hargreaves The US FDA provided 510(k) clearance for 23andMe to provide drug information for simvastatin based on the genetics of users of the service.
Statins may reduce risk of COVID-19 death: researchers 19-Jul-2021 By Jenni Spinner A recent study indicates patients taking the cholesterol-lowering drugs prior to COVID hospitalization are far less likely to die as a result of the virus.
NEWS IN BRIEF Aurobindo recalls 2,352 bottles of statins from US market 09-Sep-2019 By Ben Hargreaves Aurobindo’s US subsidiary issues a voluntary recall of statin tablets, after the bottles were found to be incorrectly labelled.